Financials

  • Market Capitalization 614.58 M
  • Employee 371
  • Founded 2008
  • CEO N/A
  • Website www.regenxbio.com
  • Headquarter Maryland, United States
  • FIGI BBG007Z9V591
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.16
Relación precio/flujo de caja
3.61

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
2737
CRMD
CorMedix Inc. - Common Stock
8.38 USD+1.45%-2.10%+10.26%-25.84%653.17 M USD
2745
MPLT
MapLight Therapeutics, Inc. - Common Stock
13.36 USD+3.01%+6.54%+3.97%-29.68%619.61 M USD
2768
AUTL
Autolus Therapeutics plc - American Depositary Shares
2.31 USD-1.70%-5.33%+34.30%+56.08%614.84 M USD
2773
TECX
Tectonic Therapeutic, Inc. - Common Stock
31.37 USD+4.78%-16.81%+12.84%+82.92%613.26 M USD

Noticias